A PYMNTS Company

China: Bayer latest multinational to come under competition watch

By  |  September 15, 2013

German pharmaceutical giant Bayer confirmed Friday it is the subject of an antitrust investigation by Chinese regulators, though details of the probe are scarce.

A spokesperson for Bayer told reporters that a local unit of the Administration for Industry and Commerce searched Bayer offices following competition concerns; the spokesperson said Bayer is “fully cooperating” with regulators.

The investigation comes at a time when reports say Chinese competition regulators are zeroing-in on multinational firms and cracking down on certain sectors of the market, including the pharmaceutical industry.

Full Content: Pharma Times

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.